๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

151 REDUCED DOSE AND DURATION OF SORAFENIB TREATMENT ARE ASSOCIATED TO TUMOR PROGRESSION IN PATIENTS WITH HEPATOCELLULAR CARCINOMA

โœ Scribed by F.R. Ponziani; B.E. Annichiarico; M. Siciliano; C. Barone; M. Basso; V. Cesario; M. Campanale; G. Caracciolo; M. Garcovich; M. Zocco; G. Gigante; E. Rinninella; G. Sarno; T.A. Di Rienzo; F. D'Aversa; G. Gasbarrini; A. Gasbarrini


Book ID
117380363
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
76 KB
Volume
56
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Over-expression and lack of retinoblasto
โœ Ai-Min Hui; Xin Li; Masatoshi Makuuchi,; Tadatoshi Takayama; Keiichi Kubota ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 352 KB ๐Ÿ‘ 2 views

To determine the role of retinoblastoma (Rb) gene alteration in hepatocarcinogenesis, we examined Rb protein expression immuno-histochemically in a series of surgically resected specimens including non-cancerous liver tissues with cirrhosis or chronic hepatitis, large regenerative nodules, pre-cance